Study of GS-1219 in Participants With HIV-1

NCT07115368 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision to terminate study.

Conditions

HIV-1-infection

Interventions

DRUG: GS-1219
DRUG: BVY
DRUG: Standard of Care

Sponsor

Gilead Sciences